ホールスライドイメージング市場レポート：動向、予測、競合分析 (2031年まで)

世界のホールスライドイメージング (WSI) 市場の将来は、遠隔病理学、細胞病理学、免疫組織化学、血液病理学市場での機会により有望視されています。世界のホールスライドイメージング市場は、2025年から2031年にかけてCAGR 6.5%で成長すると予測されています。この市場の主な促進要因は、デジタル病理ソリューションの採用拡大、創薬研究活動の拡大、効率的で正確な診断に対するニーズの高まりです。

• Lucintelの予測では、技術別ではスキャナーが予測期間中に最も高い成長を遂げる見込みです。
• 用途別では、テレパソロジーが予測期間中に最も高い成長が見込まれます。
• 地域別では、北米が予測期間で最も高い成長が見込まれます。

ホールスライドイメージング市場の戦略的成長機会

ホールスライドイメージング市場は、診断業務と患者の転帰を大幅に向上させる数多くの戦略的成長機会を提供します。技術が進歩し続け、医療ニーズが進化する中、利害関係者はこれらの機会を活用することで、リーチを拡大し、サービスを向上させることができます。このような成長分野を特定し行動することで、急速に変化する情勢の中で持続的な競合優位性を得ることができます。

• テレパソロジー（遠隔病理診断）サービスの拡大：テレパソロジーのニーズの高まりは、ホールスライドイメージングプロバイダーにとって、特に十分なサービスを受けていない地域における遠隔診断能力を強化し、専門家による診察を容易にし、質の高い医療へのアクセスを改善する機会を提供します。
• AI主導型ソリューションの開発：AI技術に投資することで、画像解析を強化し、診断プロセスを自動化し、精度を向上させる、より高度なホールスライドイメージングプラットフォームを開発することが可能となり、信頼性の高い診断ツールに対する需要の高まりに応えることができます。
• 教育機関との連携：大学や研究センターと提携し、トレーニングプログラムや研究イニシアチブを開発することで、ホールスライドイメージング技術に精通した熟練した人材を育成し、その採用を促進し、臨床現場での効果的な活用を確保することができます。
• 電子カルテ（EHR）との統合を重視する：ホールスライドイメージングシステムとEHRの相互運用性を高めることで、ワークフローを合理化し、データ共有を改善し、病理医が患者の病歴にすぐにアクセスできるようにして、診断プロセス全体を向上させることができます。
• 新興市場の開拓：新興市場への事業拡大は大きな成長機会となります。これらの地域では医療インフラが整備されるにつれ、デジタル病理学ソリューションに対する需要が高まりっており、それをカスタム型のホールスライドイメージングで解消することができます。

ホールスライドイメージング市場には、イノベーションを促進し、医療提供を改善する戦略的成長機会が豊富にあります。利害関係者は、これらの機会を活用することで、成功に向けて自らを位置づけ、デジタルパソロジーの進化に有意義な貢献をすることができます。

ホールスライドイメージング市場促進要因・課題

ホールスライドイメージング市場には、イノベーションを促進し、医療提供を改善する戦略的成長機会が豊富にあります。利害関係者は、これらの機会を活用することで、成功に向けて自らを位置づけ、デジタルパソロジーの進化に有意義な貢献をすることができます。

ホールスライドイメージング市場全体を牽引する要因は以下の通りです：

• デジタル病理学に対する需要の増加：効率的で正確な診断ツールに対するニーズの高まりは、医療提供者が患者の転帰を改善し、ワークフロープロセスを合理化しようとしていることから、WSIの採用を促進しています。
• 技術の進歩：高解像度化や優れた解析ソフトウェアなど、画像処理技術の絶え間ない進歩がWSIシステムの能力を高め、効果的なソリューションを求める医療機関にとって魅力的なものとなっています。
• 規制当局の承認とサポート：FDA（米国食品医薬品局）などの規制当局によるWSI技術の承認が進むことで、医療従事者の信頼が高まり、デジタル病理診断への投資が促進され、市場の成長が加速しています。
• 人工知能の統合：WSIシステムへのAIの統合は、より迅速で正確な画像解析を可能にし、病理医が十分な情報に基づいた判断を下せるようにし、患者ケア全体を向上させることで、診断に革命をもたらしています。
• 遠隔医療の採用拡大：遠隔医療、特にパンデミック後の遠隔医療の受け入れ拡大は、遠隔病理学ソリューションの需要を促進し、WSIを遠隔診察に不可欠なツールとし、専門家による治療へのアクセスを向上させています。

ホールスライドイメージング市場の課題は以下の通りです：

• 初期コストの高さ：WSIシステムの導入に伴う高額なコストは、多くの医療施設、特に予算が限られている小規模施設にとって大きな障壁となり、普及の妨げとなる可能性があります。
• データプライバシーへの懸念：WSIは、機密性の高い患者情報のデジタル保存と共有に依存しているため、データプライバシーとセキュリティに関する懸念が課題となる可能性があり、患者の秘密を守るための厳格な対策が必要となります。
• 既存システムとの統合：WSI技術と既存の検査室や病院の情報システムとの統合は複雑であり、シームレスな機能を確保するためのトレーニングやリソースの追加が必要となります。

ホールスライドイメージング市場は、強力な成長促進要因・課題によって特徴付けられています。これらの課題に対処しながら促進要因を活用することで、利害関係者は戦略を最適化し、デジタル病理ソリューションの導入の成功に貢献することができます。

目次

第1章 エグゼクティブサマリー

第2章 世界のホールスライドイメージング市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界のホールスライドイメージング市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界のホールスライドイメージング市場：技術別
  • スキャナー
  • ITインフラ
  • ビューアー
  • 画像管理システム
• 世界のホールスライドイメージング市場：用途別
  • テレパソロジー（遠隔病理診断）
  • 細胞病理学
  • 免疫組織化学
  • 血液病理学
  • その他
• 世界のホールスライドイメージング市場：最終用途別
  • 学術機関
  • 研究
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界のホールスライドイメージング市場：地域別
• 北米のホールスライドイメージング市場
• 欧州のホールスライドイメージング市場
• アジア太平洋のホールスライドイメージング市場
• その他地域のホールスライドイメージング市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のホールスライドイメージング市場の成長機会：技術別
  • 世界のホールスライドイメージング市場の成長機会：用途別
  • 世界のホールスライドイメージング市場の成長機会：最終用途別
  • 世界のホールスライドイメージング市場の成長機会：地域別
• 世界のホールスライドイメージング市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のホールスライドイメージング市場の生産能力拡大
  • 世界のホールスライドイメージング市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Olympus Corporation
• Koninklijke Philips
• Leica Microsystems
• Nikon Corporation
• Visiopharm
• 3Dhistech
• Hamamatsu Photonics KK
• Indica Labs
• Mikroscan Technologies
• Akoya Biosciences

The future of the global whole slide imaging market looks promising with opportunities in the telepathology, cytopathology, immunohistochemistry, and hematopathology markets. The global whole slide imaging market is expected to grow with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing adoption of digital pathology solutions, expanding research activities of drug discovery, and the rising need for efficient and accurate diagnosis.

• Lucintel forecasts that, within the technology category, scanner is expected to witness the highest growth over the forecast period.
• Within the application category, telepathology is expected to witness the highest growth over the forecast period.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Whole Slide Imaging Market

The whole slide imaging market is evolving rapidly, influenced by technological advancements and changing healthcare needs. As the demand for efficient and accurate diagnostic solutions grows, several trends are shaping the future of whole slide imaging. These trends reflect the integration of artificial intelligence, improved workflow efficiencies, and increased accessibility of digital pathology.

• Integration of Artificial Intelligence: The incorporation of AI algorithms in whole slide imaging is enhancing diagnostic accuracy and speed, enabling pathologists to identify abnormalities more effectively and reducing the potential for human error.
• Cloud-Based Solutions: The shift toward cloud-based storage and analysis is allowing greater data accessibility and collaboration among healthcare professionals, making it easier to share and review slides remotely, thus streamlining workflows.
• Telepathology Adoption: The rise of telepathology is transforming how pathology services are delivered, particularly in remote or underserved areas, facilitating consultations and second opinions through digital slide sharing, which enhances patient care.
• Regulatory Support: Increasing regulatory approvals for whole slide imaging technologies by bodies like the FDA are driving market growth. These approvals foster confidence in digital pathology solutions and encourage healthcare institutions to adopt these innovations.
• Educational Initiatives: Growing emphasis on educational programs and training for pathologists on whole slide imaging technology is crucial. As professionals become more familiar with digital tools, the adoption rate is expected to rise, promoting better diagnostic practices.

The whole slide imaging market is poised for significant advancements driven by these emerging trends. As technology continues to evolve, stakeholders in healthcare are likely to see enhanced diagnostic capabilities and improved patient outcomes, marking a new era in pathology.

Recent Developments in the Whole Slide Imaging Market

The whole slide imaging market is experiencing rapid advancements, driven by technological innovations, regulatory changes, and increased adoption in clinical settings. These developments are reshaping the landscape of digital pathology, making diagnostic processes more efficient and accurate. As healthcare continues to evolve, key milestones highlight the potential of whole slide imaging to transform pathology practices and improve patient care.

• Increased AI Integration: Recent advancements in artificial intelligence are enhancing whole slide imaging applications, with algorithms now capable of analyzing slides for complex patterns, thereby supporting pathologists in diagnostics and improving accuracy and speed.
• Expansion of Regulatory Approvals: Regulatory bodies, such as the FDA, are increasingly approving whole slide imaging systems for clinical use. These approvals not only validate the technology's reliability but also encourage healthcare facilities to invest in digital pathology solutions.
• Advancements in Image Analysis Software: The development of sophisticated image analysis software is enabling more detailed examination of whole slide images, allowing pathologists to extract valuable insights and supporting more informed clinical decisions based on enhanced visualization.
• Growth of Remote Pathology Services: The demand for remote pathology services is on the rise, particularly following the pandemic. Whole slide imaging technology is facilitating telepathology, enabling specialists to provide consultations and diagnostics from distant locations efficiently.
• Increased Investment in Research: Significant investments in research and development by both public and private sectors are driving innovation in whole slide imaging technologies. These funds are aimed at enhancing functionality, improving interoperability, and advancing education in digital pathology.

Recent developments in the whole slide imaging market reflect a dynamic evolution in the field of pathology. With ongoing innovations and growing acceptance among healthcare professionals, whole slide imaging is set to play a pivotal role in transforming diagnostic practices and enhancing patient outcomes in the coming years.

Strategic Growth Opportunities for Whole Slide Imaging Market

The whole slide imaging market presents numerous strategic growth opportunities that can significantly enhance diagnostic practices and patient outcomes. As technology continues to advance and healthcare needs evolve, stakeholders can leverage these opportunities to expand their reach and improve services. Identifying and acting on these growth areas can lead to sustained competitive advantages in a rapidly changing landscape.

• Expanding Telepathology Services: The growing need for telepathology offers an opportunity for whole slide imaging providers to enhance remote diagnostic capabilities, particularly in underserved regions, facilitating expert consultations and improving access to quality healthcare.
• Development of AI-Driven Solutions: Investing in AI technologies can enable companies to create more advanced whole slide imaging platforms that enhance image analysis, automate diagnostic processes, and improve accuracy, thereby meeting the increasing demand for reliable diagnostic tools.
• Collaboration with Educational Institutions: Partnering with universities and research centers to develop training programs and research initiatives can foster a skilled workforce familiar with whole slide imaging technology, promoting its adoption and ensuring effective utilization in clinical practice.
• Focus on Integration with Electronic Health Records (EHR): Enhancing interoperability between whole slide imaging systems and EHRs can streamline workflows, improve data sharing, and ensure that pathologists have immediate access to patient histories, thereby enhancing the overall diagnostic process.
• Exploring Emerging Markets: Expanding operations into emerging markets presents a significant growth opportunity. As healthcare infrastructure develops in these regions, there is a rising demand for digital pathology solutions, which can be met with tailored whole slide imaging offerings.

The whole slide imaging market is ripe with strategic growth opportunities that can drive innovation and improve healthcare delivery. By capitalizing on these avenues, stakeholders can position themselves for success and make meaningful contributions to the evolution of digital pathology.

Whole Slide Imaging Market Driver and Challenges

The whole slide imaging market is ripe with strategic growth opportunities that can drive innovation and improve healthcare delivery. By capitalizing on these avenues, stakeholders can position themselves for success and make meaningful contributions to the evolution of digital pathology.

The factors responsible for driving the whole slide imaging market include:

• Increasing Demand for Digital Pathology: The rising need for efficient and accurate diagnostic tools is driving the adoption of WSI, as healthcare providers seek to improve patient outcomes and streamline workflow processes.
• Advancements in Technology: Continuous advancements in imaging technology, including higher resolution and better analysis software, are enhancing the capabilities of WSI systems, making them more appealing to medical institutions looking for effective solutions.
• Regulatory Approvals and Support: Growing regulatory approvals for WSI technologies from agencies like the FDA are fostering trust and encouraging healthcare providers to invest in digital pathology, thereby accelerating market growth.
• Integration of Artificial Intelligence: The integration of AI into WSI systems is revolutionizing diagnostics by enabling faster and more accurate image analysis, helping pathologists make informed decisions, and improving overall patient care.
• Expanding Telemedicine Adoption: The increased acceptance of telemedicine, particularly post-pandemic, is driving demand for telepathology solutions, making WSI an essential tool for remote consultations and enhancing access to expert care.

Challenges in the whole slide imaging market are:

• High Initial Costs: The high costs associated with implementing WSI systems can be a significant barrier for many healthcare facilities, especially smaller institutions with limited budgets, which may hinder widespread adoption.
• Data Privacy Concerns: As WSI relies on digital storage and sharing of sensitive patient information, concerns about data privacy and security can pose challenges, requiring stringent measures to protect patient confidentiality.
• Integration with Existing Systems: The complexity of integrating WSI technology with existing laboratory and hospital information systems can create operational hurdles, necessitating additional training and resources to ensure seamless functionality.

The whole slide imaging market is characterized by strong growth drivers and notable challenges. By addressing these challenges while capitalizing on the drivers, stakeholders can optimize their strategies and contribute to the successful implementation of digital pathology solutions.

List of Whole Slide Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies whole slide imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the whole slide imaging companies profiled in this report include-

• Olympus Corporation
• Koninklijke Philips
• Leica Microsystems
• Nikon Corporation
• Visiopharm
• 3Dhistech
• Hamamatsu Photonics KK
• Indica Labs
• Mikroscan Technologies
• Akoya Biosciences

Whole Slide Imaging by Segment

The study includes a forecast for the global whole slide imaging market by technology, application, end use, and region.

Whole Slide Imaging Market by Technology [Analysis by Value from 2019 to 2031]:

• Scanners
• IT Infrastructure
• Viewer
• Image Management System

Whole Slide Imaging Market by Application [Analysis by Value from 2019 to 2031]:

• Telepathology
• Cytopathology
• Immunohistochemistry
• Hematopathology
• Others

Whole Slide Imaging Market by End Use [Analysis by Value from 2019 to 2031]:

• Academic Institute
• Research
• Others

Whole Slide Imaging Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Whole Slide Imaging Market

The whole slide imaging market has witnessed significant growth recently, driven by advancements in digital pathology, increasing adoption of telepathology, and rising demand for efficient diagnostic tools. This technology enhances the accuracy of pathology assessments, facilitates remote consultations, and supports educational initiatives. As the market evolves, key players are expanding their offerings and exploring innovative solutions. This report highlights recent developments in the whole slide imaging market across the United States, China, Germany, India, and Japan.

• United States: The U.S. market is rapidly expanding due to increased investments in healthcare technology and regulatory approvals, with companies focusing on enhancing AI integration to improve diagnostic accuracy and workflow efficiency.
• China: The Chinese whole slide imaging market is experiencing robust growth, fueled by government initiatives to modernize healthcare, coupled with rising demand for digital solutions among hospitals and laboratories, as well as significant investments in research and development.
• Germany: Germany is at the forefront of whole slide imaging technology in Europe, driven by strong research institutions and healthcare partnerships. Ongoing regulatory support and funding for innovative solutions are further propelling the market's expansion.
• India: The Indian whole slide imaging market is gaining momentum as healthcare facilities adopt digital pathology solutions. Increasing awareness of the benefits of whole slide imaging among pathologists and educational institutions is encouraging growth in this sector.
• Japan: Japan is leveraging its advanced technology landscape to enhance whole slide imaging applications. The government's focus on digital transformation in healthcare is fostering collaborations between tech companies and medical institutions to improve diagnostic processes.

Features of the Global Whole Slide Imaging Market

Market Size Estimates: Whole slide imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Whole slide imaging market size by technology, application, end use, and region in terms of value ($B).

Regional Analysis: Whole slide imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, applications, end uses, and regions for the whole slide imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the whole slide imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the whole slide imaging market by technology (scanners, IT infrastructure, viewer, and image management system), application (telepathology, cytopathology, immunohistochemistry, hematopathology, and others), end use (academic institute, research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Whole Slide Imaging Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Whole Slide Imaging Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Whole Slide Imaging Market by Technology
  • 3.3.1: Scanners
  • 3.3.2: IT Infrastructure
  • 3.3.3: Viewer
  • 3.3.4: Image Management System
• 3.4: Global Whole Slide Imaging Market by Application
  • 3.4.1: Telepathology
  • 3.4.2: Cytopathology
  • 3.4.3: Immunohistochemistry
  • 3.4.4: Hematopathology
  • 3.4.5: Others
• 3.5: Global Whole Slide Imaging Market by End Use
  • 3.5.1: Academic Institute
  • 3.5.2: Research
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Whole Slide Imaging Market by Region
• 4.2: North American Whole Slide Imaging Market
  • 4.2.1: North American Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.2.2: North American Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
• 4.3: European Whole Slide Imaging Market
  • 4.3.1: European Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.3.2: European Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
• 4.4: APAC Whole Slide Imaging Market
  • 4.4.1: APAC Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.4.2: APAC Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
• 4.5: ROW Whole Slide Imaging Market
  • 4.5.1: ROW Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.5.2: ROW Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Whole Slide Imaging Market by Technology
  • 6.1.2: Growth Opportunities for the Global Whole Slide Imaging Market by Application
  • 6.1.3: Growth Opportunities for the Global Whole Slide Imaging Market by End Use
  • 6.1.4: Growth Opportunities for the Global Whole Slide Imaging Market by Region
• 6.2: Emerging Trends in the Global Whole Slide Imaging Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Whole Slide Imaging Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Whole Slide Imaging Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Olympus Corporation
• 7.2: Koninklijke Philips
• 7.3: Leica Microsystems
• 7.4: Nikon Corporation
• 7.5: Visiopharm
• 7.6: 3Dhistech
• 7.7: Hamamatsu Photonics KK
• 7.8: Indica Labs
• 7.9: Mikroscan Technologies
• 7.10: Akoya Biosciences